Regenxbio (RGNX) FCF Margin (2014 - 2025)
Regenxbio's FCF Margin was -174.04% in Q4 2025, down 19.88 percentage points from -154.16% a year earlier but up 15.82 percentage points from the prior quarter.
Powered by 
Analysis
Regenxbio (RGNX) FCF Margin (2014 - 2025) Analysis & Trends
For FY2025, FCF Margin at Regenxbio came in at -74.15%, up 136.54 percentage points from FY2024.
- FCF Margin shows a five-year change of -21.79 percentage points (FY2020 to FY2025).
- In earlier years, FCF Margin was -210.69% in FY2024 (+42.37 pp), -253.06% in FY2023 (-41.74 pp), -211.32% in FY2022 (-239.96 pp) and 28.64% in FY2021 (+81.00 pp).
- Quarterly FCF Margin has moved between -447.99% (Q1 2023) and 82.00% (Q4 2021) over five years.
- Compared with a year earlier, FCF Margin has declined for three straight quarters, with an average year-over-year change of +62.76 percentage points over the last eight quarters.
- The best year-over-year quarter for FCF Margin over five years was Q1 2025 (a gain of 395.18 percentage points); the worst was Q4 2022 (a drop of 225.06 percentage points).
- Per Business Quant data, RGNX's FCF Margin in the three quarters before Q4 2025 was -189.86% (Q3 2025), -232.84% (Q2 2025) and 36.63% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 30.39% |
| 10 | Regenxbio | 407.85 Mn | -525.24 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -174.04% |
| Sep 30, 2025 | -189.86% |
| Jun 30, 2025 | -232.84% |
| Mar 31, 2025 | 36.63% |
| Dec 31, 2024 | -154.16% |
| Sep 30, 2024 | -168.93% |
| Jun 30, 2024 | -206.19% |
| Mar 31, 2024 | -358.55% |
| Dec 31, 2023 | -188.57% |
| Sep 30, 2023 | -175.85% |
| Jun 30, 2023 | -249.78% |
| Mar 31, 2023 | -447.99% |
| Dec 31, 2022 | -143.06% |
| Sep 30, 2022 | -209.36% |
| Jun 30, 2022 | -217.42% |
| Mar 31, 2022 | -301.01% |
| Dec 31, 2021 | 82.00% |
| Sep 30, 2021 | -198.88% |
| Jun 30, 2021 | -253.75% |
| Mar 31, 2021 | -397.52% |
API Access
Regenxbio FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();